Skip to Content

Are you based in North America? If yes, switch to our North American website →

IGH/MALT1 Translocation, Dual Fusion

Catalogue Numbers
LPS 034 (10 tests)
LPS 034-S (5 tests)

The t(14;18)(q32;q21) involving the Immunoglobulin heavy chain locus (IGH) at 14q32 and the Mucosa Associated Lymphoid Tissue Lymphoma Translocation gene 1 (MALT1) at 18q21 is a recurrent abnormality in MALT lymphoma1.

Extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue is listed as a distinct clinicopathologic entity. MALT lymphomas comprise 7.6% of all non-Hodgkin lymphoma's (NHLs) and represents 1 of the 6 most common NHLs2. MALT lymphomas are characterised by a proliferation of neoplastic marginal zone-related cells that invade the epithelial structures to generate lymphoepithelial lesions and colonise reactive lymphoid follicles3. t(14;18)/IGH-MALT1- positive MALT lymphomas originate in sites such as the liver, skin, ocular adnexa, or salivary glands1. The molecular characteristics of the t(14;18) resemble those found in the t(14;18)/IGH-BCL2 (follicular lymphoma) and t(11;14)/MALT1-IGH (mantle cell lymphoma), suggesting that these translocations could be generated by common pathomechanisms involving illegitimate V(D)J-mediated recombination of IGH as well as non-homologous end joining (NHEJ) or alternative NHEJ repair pathways1.


1. Murga Penas EM et al., Blood 2010;115(11):2214-9

2. Streubel B et al., Blood 2003;101:2335-2339

3. Bacon et al., J Clin Pathol 2007;60:361–372

Microscope Images

IGH MALT1 Translocation Dual Fusion magnified
Area of Interest*


This product is intended to be used on Carnoy’s solution (3:1 methanol/acetic acid) fixed haematological samples, or formalin-fixed paraffin-embedded (FFPE) tissues.

*Disease information supported by the literature and is not a reflection of the intended purpose of this product.